Zymergen (ZY) Financials

$2.43

$0.00 (0.00%)

As on 19-Oct-2022 09:30EDT

Market cap

$254 Mln

Revenue (TTM)

$14 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	14.09	16.74	13.28	15.42	--	--
Cost of Revenue	48.95	69.72	84.82	102.64	--	--
Gross Profit	-34.86	-52.98	-71.53	-87.22	--	--
Operating Expenses	232.31	265.78	169.56	136.10	--	--
Operating Profit (EBIT)	-336.31	-347.56	-241.09	-237.11	--	--
Other Income	-1.56	--	--	--	--	--
Profit before Tax	-364.91	-361.73	-262.24	-236.80	--	--
Provision for Tax	0.04	0.05	-0.05	0.01	--	--
Profit after Tax (Net Income)	-364.95	-361.79	-262.19	-236.80	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-364.95	-361.79	-262.19	-236.80	--	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	236.62	408.49	-743.74	-499.58	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	182.15	40.36	927.20	615.79	--	--
Current Liabilities	52.20	73.55	121.46	111.68	--	--
Total Liabilities	523.16	522.40	304.92	227.89	--	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	231.33	115.05	76.35	61.90	--	--
Current Assets	239.64	407.35	228.57	166.00	--	--
Total Assets	523.16	522.40	304.92	227.89	--	--
Total Debt*	186.08	43.95	79.33	78.31	--	--
Net Current Assets	187.45	333.82	107.12	54.32	--	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-302.47	-223.20	-195.56	--	--
Cash Flow from Investing Activities	--	-32.20	-17.05	-22.85	--	--
Cash from Financing Activities	--	513.76	297.01	37.60	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-3.85	-4.89	-21.85	--	--	--
Cash EPS ($)	--	-4.61	-20.29	--	--	--
Adjusted Book Value ($)	--	5.52	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.09	-18.60	--	--	--
Free Cash Flow per Share ($)	--	-4.54	-20.03	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	341.36	48.30	--	--	--
ROE (%)	-132.28	215.83	42.18	--	--	--
ROA (%)	-56.13	-87.46	-98.42	--	--	--
EBIT Margin (%)	-2,400.46	-2,072.68	-1,891.62	-1,516.65	--	--
Net Margin (%)	-2,911.22	-2,160.81	-1,973.76	-1,535.79	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	-24.79	0.26	-0.14	--	--	--
EBIT Growth (%)	-41.55	-38.10	-7.45	--	--	--
Net Profit Growth (%)	-32.16	-37.98	-10.72	--	--	--
EPS Growth (%)	79.58	0.78	--	--	--	--
Book Value Growth (%)	-68.53	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-1.37	--	--	--	--
Price / Book Value	1.07	1.21	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.71	-0.47	--	--	--	--
Close Price ($)	1.23	6.69	--	--	--	--
High Price ($)	41.93	52.00	--	--	--	--
Low Price ($)	1.10	6.40	--	--	--	--
Market Cap ($ Cr)	253.58	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.11	-0.11	-0.16	--	--
Short term debt to equity ratio	0.03	0.11	-0.11	-0.16	--	--
Current Ratio	4.59	5.54	1.88	1.49	--	--
Quick Ratio	4.47	5.46	1.84	1.47	--	--
Interest Coverage	-12.70	-23.60	-22.93	-79.46	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	26.23	18.43	34.67	19.77	--	--
Asset Turnover	0.02	0.04	0.05	--	--	--
Receivable days	--	83.89	105.23	72.20	--	--
Inventory Days	--	28.82	15.50	7.93	--	--
Payable days	--	45.88	56.71	50.68	--	--
Cash Conversion Cycle	--	66.84	64.01	29.45	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.